WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: JUNE ISSUE PUBLISHED

    JUNE 2022 Issue has been successfully launched on 1 June 2022

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 June Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

COMPARISON OF PLATELET AGGREGATION RESPONSE IN TYPE 2 DIABETES AND NORMAL SUBJECTS

*Dr. R. Anil Kumar MD, WHO Fellowship in Diabetology. FICP, FCCP

ABSTRACT

Aims and objectives- To compare the platelet aggregation response in type 2 diabetes subjects and normal subjects. Research methods- 80 subjects with type 2 Diabetes Mellitus and 40 normal subjects were randomly selected. FPG, PPPG, HBA1c and platelet aggregation response were studied. Results - The mean age was 52.16±11.28 in the case group and 41.4±10.43 in the control group. There were 50 and 21 number of male subjects and 30 and 19 number of female subjects in the case and control group respectively. The mean fasting plasma glucose was 150.08±54.52 and 88.70±13.36 in the case and control group respectively. The mean post prandial plasma glucose was 233.98±82.99 and 129.95±15.27, mean HBA1c was 8.08±1.84 and 5.50±.42 in the case and control group respectively. The duration of diabetes ranged from newly detected diabetics to those with disease duration of more than 10 years. Platelet aggregation responses to ADP and epinephrine were measured and results were recorded as percentage for both groups. The difference between the case and control groups in the platelet aggregation responses induced was statistically insignificant. Conclusions- The platelet aggregation responses induced by ADP and epinephrine were similar in type 2 diabetes and normal subjects. So the routine use of anti platelet agents may not be necessary in all type 2 diabetes subjects for primary prevention of cardiovascular diseases. Anti platelet drugs can be used in secondary prevention and high risk patients. This is a small study done in a single centre. So a large multicentre study is necessary to prove this.

[Full Text Article]